Replies to post #774359 on NorthWest Biotherapeutics Inc (NWBO)

[Chiugray]

Slave1, Didn't know that. That little summary speaks a thousand words.

It’s on public record: Linda Powers was the sole representative from the oncology cell therapy sector to testify during the UK Parliament’s APPGBT inquiry in May 2022. Her recommendations were cited directly in the final report, and the MHRA reforms that followed, including SI 87, External Control Arm guidance, and the Real-World Evidence Joint Scientific Dialogue, align point for point with what she advocated.
...
This isn’t just about treating UK patients, it’s about enabling economic leverage. The UK gets jobs, GMP infrastructure, global licensing pull, and platform delivery. DCVax becomes not just a treatment, but the model that proves the NHS platform works.